Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
2007 1
2008 2
2009 8
2010 10
2011 13
2012 10
2013 9
2014 18
2015 22
2016 25
2017 14
2018 18
2019 25
2020 33
2021 25
2022 27
2023 30
2024 33
2025 39

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Results by year

Filters applied: . Clear all
Page 1
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis.
Sanyal AJ, Nakajima A, Bugianesi E, Sebastiani G, Schattenberg JM, Adams LA, Noureddin M, Yoneda M, Bedossa P, Younossi ZM, Alfadda AA, Geier A, Tacke F, Marchesini G, Targher G, Al-Omar HA, Hagström H, Abraldes JG, Boursier J, Imajo K, Opuni K, Bertot LC, Alkhouri N, Tamaki N, Loomba R, Ota R, Pais R, Friedman SL, Jayakumar S, Petta S, Ratziu V, Wai-Sun Wong V. Sanyal AJ, et al. Among authors: alkhouri n. Clin Gastroenterol Hepatol. 2025 Dec 6:S1542-3565(25)01014-6. doi: 10.1016/j.cgh.2025.12.001. Online ahead of print. Clin Gastroenterol Hepatol. 2025. PMID: 41360159
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 24-week results from a multicentre, randomised, double-blind, phase 2b study.
Noureddin M, Harrison SA, Loomba R, Alkhouri N, Chalasani N, Sheikh MY, Tomah S, Gutierrez JA, Urbina S, Suschak JJ, Brown R, Odili O, Yang J, Keeton S, Neff G, Mena E, Roberts MS, Browne SK, Harris MS. Noureddin M, et al. Among authors: alkhouri n. Lancet. 2025 Dec 6;406(10520):2644-2655. doi: 10.1016/S0140-6736(25)02114-2. Epub 2025 Nov 11. Lancet. 2025. PMID: 41237796 Clinical Trial.
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study.
Younossi ZM, de Avila L, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Ananchuensook P, Shalimar, Tsochatzis E, Trivikrama SK, Balakumaran LK, Fan JG, Roberts SK, Alswat K, Wong VW, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Goh GB, Oliveira CP, Pessoa MG, Chan WK, Fernandez MIC, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, Alnaamani K, Holleboom AG, Valsan A, Venu A, El-Kassas M, Pennisi G, Shang Y, Liu WY, Lee HW, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Iruzubieta P, Nadeem R, Cinque F, Neonaki A, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, The KK, Mahadeva S, Fabian LG, Almohsen A, Leite N, Pugliese N, Vessby J, Xie C, Choudhary NS, Friend E, Poca M, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Segrestin B, Gunn N, Mauricio D, Arrese M, Fracanzani A, Lam B, Racila A, Alqahtani SA, Stepanova M; Global NASH/MASH Council (GNC). Younossi ZM, et al. Among authors: alkhouri n. Hepatology. 2025 Nov 13. doi: 10.1097/HEP.0000000000001617. Online ahead of print. Hepatology. 2025. PMID: 41231627
Cost-Effectiveness of MASH Diagnosis and Management Approaches Among Those With Type 2 Diabetes.
Lazarus JV, Agirre-Garrido L, Díaz LA, Danpanichkul P, Kivuyo SL, Kondili LA, Hagström H, Takahashi H, Pericàs JM, Spearman CW, Oliveira CP, Villela-Nogueira CA, Schattenberg JM, Toresson Grip E, Alkhouri N, Marcellusi A, Mark HE, Allen AM, Carvalho Leite N, Al-Omar HA, Alqahtani SA, Brachowicz N. Lazarus JV, et al. Among authors: alkhouri n. JAMA Netw Open. 2025 Nov 3;8(11):e2542750. doi: 10.1001/jamanetworkopen.2025.42750. JAMA Netw Open. 2025. PMID: 41196592 Free PMC article.
Effects of Resmetirom on Metabolic-Dysfunction Associated Steatohepatitis in Patients With Weight Loss and/or Diabetes Taking Glucagon-Like Peptide-1 Receptor Agonists and Other Diabetes Therapies: A Secondary Analysis of the MAESTRO-NASH Trial.
Noureddin M, Rinella M, Taub R, Labriola D, Camacho RC, Alkhouri N, Loomba R, Bansal MB. Noureddin M, et al. Among authors: alkhouri n. Aliment Pharmacol Ther. 2025 Dec;62(11-12):1089-1099. doi: 10.1111/apt.70382. Epub 2025 Oct 23. Aliment Pharmacol Ther. 2025. PMID: 41127972 Free PMC article. Clinical Trial.
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study.
Younossi ZM, de Avila L, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Ananchuensook P, Shalimar D, Tsochatzis E, Trivikrama SK, Balakumaran LK, Fan JG, Roberts SK, Alswat K, Wong VW, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Goh GB, Oliveira CP, Pessoa MG, Chan WK, Fernandez MIC, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, Alnaamani K, Holleboom AG, Valsan A, Venu A, El-Kassas M, Pennisi G, Shang Y, Liu WY, Lee HW, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Iruzubieta P, Nadeem R, Cinque F, Neonaki A, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, The KK, Mahadeva S, Fabian LG, Almohsen A, Leite N, Pugliese N, Vessby J, Xie C, Choudhary NS, Friend E, Poca M, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Segrestin B, Gunn N, Mauricio D, Arrese M, Fracanzani A, Brian Lam PA, Racila A, Alqahtani SA, Stepanova M; Global NASH/MASH Council (GNC). Younossi ZM, et al. Among authors: alkhouri n. Hepatology. 2025 Oct 8. doi: 10.1097/HEP.0000000000001564. Online ahead of print. Hepatology. 2025. PMID: 41100867
312 results